D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 57 Citations 10,424 167 World Ranking 2071 National Ranking 169

Overview

What is he best known for?

The fields of study he is best known for:

  • Virus
  • Gene
  • Immune system

Tomáš Hanke spends much of his time researching Virology, Immunology, Virus, Vaccinia and Epitope. His Virology research includes themes of CD8, Antigen, Immunogenicity, Cytotoxic T cell and CTL*. In his study, Viral load and HIV Antigens is strongly linked to AIDS Vaccines, which falls under the umbrella field of Immunology.

His research in Virus focuses on subjects like Immunity, which are connected to Immunization. His work on Orthopoxvirus is typically connected to Conserved sequence as part of general Vaccinia study, connecting several disciplines of science. His work in Epitope covers topics such as Immune system which are related to areas like Clinical trial and Hiv 1 vaccine.

His most cited work include:

  • Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara (636 citations)
  • Effective Induction of Simian Immunodeficiency Virus-Specific Cytotoxic T Lymphocytes in Macaques by Using a Multiepitope Gene and DNA Prime-Modified Vaccinia Virus Ankara Boost Vaccination Regimen (314 citations)
  • Induction of AIDS Virus-Specific CTL Activity in Fresh, Unstimulated Peripheral Blood Lymphocytes from Rhesus Macaques Vaccinated with a DNA Prime/Modified Vaccinia Virus Ankara Boost Regimen (251 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of investigation include Virology, Immunology, Virus, Epitope and Vaccination. The concepts of his Virology study are interwoven with issues in T cell, Immunogenicity, Vaccinia, Cytotoxic T cell and Immunogen. His study in AIDS Vaccines extends to Immunology with its themes.

His Virus study combines topics in areas such as Viral vector, Antibody and Heterologous. His Epitope research is multidisciplinary, incorporating perspectives in Simian and CD8. His research investigates the connection between Vaccination and topics such as HIV vaccine that intersect with issues in Cellular immunity.

He most often published in these fields:

  • Virology (85.88%)
  • Immunology (48.24%)
  • Virus (38.82%)

What were the highlights of his more recent work (between 2017-2021)?

  • Virology (85.88%)
  • Epitope (42.75%)
  • Vaccination (33.73%)

In recent papers he was focusing on the following fields of study:

His scientific interests lie mostly in Virology, Epitope, Vaccination, CD8 and Immune system. Tomáš Hanke does research in Virology, focusing on Virus specifically. His Virus research integrates issues from Vaccinia, Histocompatibility and Antigen presentation.

Tomáš Hanke interconnects Cytotoxic T cell, CTL* and HIV vaccine in the investigation of issues within Epitope. His Vaccination research is under the purview of Immunology. His work in CD8 addresses subjects such as T cell, which are connected to disciplines such as Modified vaccinia Ankara and Function.

Between 2017 and 2021, his most popular works were:

  • Efficient Induction of T Cells against Conserved HIV-1 Regions by Mosaic Vaccines Delivered as Self-Amplifying mRNA. (25 citations)
  • Efficient Induction of T Cells against Conserved HIV-1 Regions by Mosaic Vaccines Delivered as Self-Amplifying mRNA. (25 citations)
  • CD8+ T cells specific for conserved, cross-reactive Gag epitopes with strong ability to suppress HIV-1 replication. (25 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Virus
  • Immune system

The scientist’s investigation covers issues in Epitope, CD8, Vaccination, Immune system and Cytotoxic T cell. CD8 is frequently linked to T cell in his study. The ELISPOT research Tomáš Hanke does as part of his general T cell study is frequently linked to other disciplines of science, such as Context, therefore creating a link between diverse domains of science.

His study explores the link between Vaccination and topics such as Immunogenicity that cross with problems in Phases of clinical research and Viremia. His Immune system study necessitates a more in-depth grasp of Immunology. In Cytotoxic T cell, Tomáš Hanke works on issues like In vivo, which are connected to Virology, In vitro, Bivalent, AIDS Vaccines and Allele.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara

Jörg Schneider;Sarah C. Gilbert;Tom J. Blanchard;Tomas Hanke.
Nature Medicine (1998)

828 Citations

Effective Induction of Simian Immunodeficiency Virus-Specific Cytotoxic T Lymphocytes in Macaques by Using a Multiepitope Gene and DNA Prime-Modified Vaccinia Virus Ankara Boost Vaccination Regimen

Tomas Hanke;Rachel V. Samuel;Tom J. Blanchard;Veronica C. Neumann.
Journal of Virology (1999)

484 Citations

Induction of AIDS Virus-Specific CTL Activity in Fresh, Unstimulated Peripheral Blood Lymphocytes from Rhesus Macaques Vaccinated with a DNA Prime/Modified Vaccinia Virus Ankara Boost Regimen

Todd M. Allen;Thorsten U. Vogel;Deborah H. Fuller;Bianca R. Mothé.
Journal of Immunology (2000)

384 Citations

HIV vaccines 1983-2003.

Andrew J McMichael;Tomas Hanke.
Nature Medicine (2003)

362 Citations

Induction of Multifunctional Human Immunodeficiency Virus Type 1 (HIV-1)-Specific T Cells Capable of Proliferation in Healthy Subjects by Using a Prime-Boost Regimen of DNA- and Modified Vaccinia Virus Ankara-Vectored Vaccines Expressing HIV-1 Gag Coupled to CD8+ T-Cell Epitopes

Nilu Goonetilleke;Stephen Moore;Len Dally;Nicola Winstone.
Journal of Virology (2006)

344 Citations

A human immunodeficiency virus 1 (HIV-1) clade A vaccine in clinical trials: stimulation of HIV-specific T-cell responses by DNA and recombinant modified vaccinia virus Ankara (MVA) vaccines in humans.

Matilu Mwau;Inese Cebere;Julian Sutton;Priscilla Chikoti.
Journal of General Virology (2004)

307 Citations

Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime

T. Hanke;T.J. Blanchard;J. Schneider;C.M. Hannan.
Vaccine (1998)

306 Citations

Design and Pre-Clinical Evaluation of a Universal HIV-1 Vaccine

Sven Létourneau;Eung-Jun Im;Tumelo Mashishi;Choechoe Brereton.
PLOS ONE (2007)

303 Citations

Design and construction of an experimental HIV-1 vaccine for a year-2000 clinical trial in Kenya.

Tomas Hanke;Andrew J. McMichael.
Nature Medicine (2000)

291 Citations

DNA multi-CTL epitope vaccines for HIV and Plasmodium falciparum: immunogenicity in mice

Tomáš Hanke;Jörg Schneider;Sarah C. Gilbert;Adrian V.S. Hill.
Vaccine (1998)

216 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Tomáš Hanke

Adrian V. S. Hill

Adrian V. S. Hill

University of Oxford

Publications: 109

Sarah C. Gilbert

Sarah C. Gilbert

University of Oxford

Publications: 79

Mariano Esteban

Mariano Esteban

Spanish National Research Council

Publications: 71

David C. Montefiori

David C. Montefiori

Duke University

Publications: 68

Bette T. Korber

Bette T. Korber

Los Alamos National Laboratory

Publications: 59

Anna-Lise Williamson

Anna-Lise Williamson

University of Cape Town

Publications: 56

David I. Watkins

David I. Watkins

University of Wisconsin–Madison

Publications: 50

Bernard Moss

Bernard Moss

National Institutes of Health

Publications: 50

Norman L. Letvin

Norman L. Letvin

Beth Israel Deaconess Medical Center

Publications: 47

Bruce D. Walker

Bruce D. Walker

Harvard University

Publications: 43

Britta Wahren

Britta Wahren

Karolinska Institute

Publications: 40

Andrew J. McMichael

Andrew J. McMichael

University of Oxford

Publications: 40

Alessandro Sette

Alessandro Sette

La Jolla Institute For Allergy & Immunology

Publications: 36

Dan H. Barouch

Dan H. Barouch

Beth Israel Deaconess Medical Center

Publications: 36

Warwick J. Britton

Warwick J. Britton

University of Sydney

Publications: 35

Josephine H. Cox

Josephine H. Cox

International AIDS Vaccine Initiative

Publications: 35

Trending Scientists

Remco Dijkman

Remco Dijkman

Eindhoven University of Technology

Annalisa Bonfiglio

Annalisa Bonfiglio

University of Cagliari

Chuansong Wu

Chuansong Wu

Shandong University

Tat Soon Yeo

Tat Soon Yeo

National University of Singapore

Joeri F. M. Denayer

Joeri F. M. Denayer

Vrije Universiteit Brussel

Paul R. Wade

Paul R. Wade

National Oceanic and Atmospheric Administration

Tom Kadesch

Tom Kadesch

University of Pennsylvania

Malcolm J. Fraser

Malcolm J. Fraser

University of Notre Dame

George Bou-Gharios

George Bou-Gharios

University of Liverpool

Huanchun Chen

Huanchun Chen

Huazhong Agricultural University

Vanaporn Wuthiekanun

Vanaporn Wuthiekanun

Mahidol Oxford Tropical Medicine Research Unit

Jocelyn McPhie

Jocelyn McPhie

University of Tasmania

Georgia Pe-Piper

Georgia Pe-Piper

Saint Mary's University

Mark E. Hodson

Mark E. Hodson

University of York

Michael Hughes

Michael Hughes

Royal Hallamshire Hospital

Mary Jane Esplen

Mary Jane Esplen

University of Toronto

Something went wrong. Please try again later.